CENTRUS ENERGY CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CENTRUS ENERGY CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	311	218	193	210	247	298	294	320	442	449
Cost of revenue	266	188	211	177	150	184	176	208	331	331
Gross profit	45.1	30.2	-17.9	32.5	97.6	115	118	112	112	118
Research and development	47.9	15.7	26.1	14.6	2.8	2.1	14.8	14.2	17.2	16.9
Selling, general and administrative	46.2	43.7	39.9	33.7	36	36	33.9	36.9	35	36.2
Operating income	-61.7	-44.7	-92.4	-19.7	51	68.3	59.7	52.4	48	50.2
Interest expense	19.7	5.3	4.1	3	0.1	0.1	0.5	1.3	2.7	14
Interest income	0.8	1.3	2.5	2.2	0.5	0.1	2	8.7	12.9	44.7
Pre-tax income	-67.6	12.1	-104	-16.2	53	136	67.8	84.5	73	85.9
Income tax	-0.6	-0.1	0	0.3	-1.4	-39.1	15.6	0.1	-0.2	8.1
Net income	-67	12.2	-104	-16.5	54.4	175	52.2	84.4	73.2	77.8
EBITDA	-48.6	-32.7	-85	-12.7	58.3	76.9	69.3	59.5	58.8	60.1
EPS, basic	-7.36	0.58	-12.23	-2.54	0.59	10.03	3.47	5.55	4.49	4.33
EPS, diluted	-7.36	0.58	-12.23	-2.54	0.57	9.75	3.38	5.44	4.47	3.90
Shares, basic (weighted)	9.1	9.08	9.15	9.57	9.83	13.5	14.6	15.2	16.3	18
Shares, diluted (weighted)	9.1	9.08	9.15	9.57	10.1	13.9	15	15.5	16.4	19.9

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	261	209	123	131	152	194	180	201	671	1,957
Receivables	19.9	60.2	60.2	21.1	29.6	29.1	38.1	49.4	80	30.7
Inventory	177	153	130	64.5	64.8	91.1	209	306	162	323
Other current assets	13.3	6.2	6.3	9.2	7.8	8.6	24.2	10.8	38.3	11.9
Total current assets	561	567	485	370	406	466	587	685	1,015	2,364
Property, plant and equipment	6	4.9	4.2	3.7	4.9	5.3	5.5	7	9.4	29.5
Lease right-of-use assets				7.2	4.6	2.1	7.9	2.7	1.6	1.8
Intangible assets	93.3	82.7	76	69.5	62.8	54.7	45.7	39.4	29.6	21.2
Other non-current assets	24.1	1.1	0.7	7.4	4.9	2.3	8.1	3.5	7.3	7
Total assets	714	675	572	456	486	572	706	796	1,093	2,446
Accounts payable	59.6	79.4	46	8.1	21.3	37.8	65.5	41.9	38.8	41.6
Accrued liabilities				50.7	50.6
Deferred revenue			0	266	283	303	273	283	216	131
Short-term debt	0	6.1	32.8	6.1	6.1	6.1	6.1	6.1	6.1	0
Total current liabilities	326	403	439	337	366	393	449	471	347	423
Lease liabilities				7	4.3	3	6.1	2.6	1.2	1
Other non-current liabilities	38.6	17.5	14.6	32.1	32.4	13.7	11.7	8.8	7.9	8
Total liabilities	950	894	894	793	807	714	780	764	932	1,681
Total debt	234	158	120	114	108	102	95.7	89.6	473	1,175
Paid-in capital	59.5	60	61.2	61.5	85	141	158	181	237	762
Retained earnings	-297	-285	-389	-405	-408	-285	-234	-150	-76.3	1.5
Other comprehensive income	0.2	0.1	-0.1	1.1	0.8	0.5	0.2	-0.3	-0.5	-0.7
Shareholders' equity	-236	-219	-322	-337	-321	-142	-74.1	32.3	161	765
Total equity	-236	-219	-322	-337	-321	-142	-74.1	32.3	161	765
Total liabilities and equity	714	675	572	456	486	572	706	796	1,093	2,446

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-67	12.2	-104	-16.5	54.4	175	52.2	84.4	73.2	77.8
Depreciation and amortization	13.1	12	7.4	7	7.3	8.6	9.6	7.1	10.8	9.9
Stock-based compensation	0.5	0.5	0.4	1.4	7.1	12.2	1.9	2.3	1.5	5.7
Deferred income tax								-1.5	-0.7	7.4
Change in receivables	6.5	-17.6	9.7	29.3	-8.6	0.5	-9	-11.3	-30.5	49.2
Change in inventory	89.5	44.7	61	0.1	26.6	-14.2	-88.5	-83.8	101	-230
Change in payables	10.4	-25.2	3.7	-12.3	-5.2	-4.6	2.6	8.5	-1.4	0.4
Cash from operations	37.7	-16.1	-74.4	11.3	67.1	50	20.6	9.1	37	51
Capital expenditures	-3	-0.5	-0.1	-0.1	-1.4	-1.2	-0.7	-1.6	-4.1	-19.7
Cash from investing	-1.2	4.2	0.4	0.6	-1.4	-1.2	-0.7	-1.6	-4.1	-19.7
Debt repaid		-3.4	-6.1	-6.1	-6.1	-6.1	-6.1	-6.1	-6.1	-3.5
Stock issued				0	23.1	42.1	3.6	23.2	54.7	524
Cash from financing	-9.8	-40	-11.1	-35	-44.4	-9.9	-4.3	13.9	437	1,225
Exchange rate effect							0	0	0.2	-0.1
Net change in cash	26.7	-51.9	-85.1	-23.1	21.3	38.9	15.6	21.4	470	1,256
Free cash flow	34.7	-16.6	-74.5	11.2	65.7	48.8	19.9	7.5	32.9	31.3
Interest paid	6.5	4.2	7.1	1.5	0			0	0	8.9
Income taxes paid	0						0	0	0.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $147.07 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	23.7%	Gross profit / revenue.
Operating margin	1.6%	Operating income / revenue.
EBITDA margin	3.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	10.0%	Pre-tax income / revenue.
Net margin	10.2%	Net income / revenue.
FCF margin	-34.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-11.6%	Cash from operations / revenue.
Effective tax rate	-2.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	5.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.9%	Net income / average total assets.
Return on invested capital (ROIC)	3.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	8.5%	Research and development expense / revenue.
SG&A / revenue	11.7%	Selling, general and administrative expense / revenue.
Capex / revenue	23.0%	Capital expenditures / revenue.
D&A / revenue	2.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	1.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	15.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	12.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	5.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	3.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	4.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-5.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-0.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	2.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-4.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	0.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	6.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	14.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	7.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-12.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	4.9%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	46.9%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	37.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	35.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-5.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-4.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	16.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-13.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	374.0%	Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	123.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	51.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	38.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	21.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	10.0%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	14.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	5.39x	Current assets / current liabilities.
Quick ratio	4.41x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	4.35x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.39x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	46.5%	Total debt / total assets.
Liabilities / assets	66.6%	Total liabilities / total assets.
Net debt	-$691.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-40.6x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	0.52x	Operating income / interest expense.
Working capital	$1.89B	Current assets - current liabilities.
Goodwill and intangibles / assets	0.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	$828.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.19x	Revenue / average total assets.
Fixed asset turnover	3.33x	Revenue / average property, plant and equipment.
Inventory turnover	0.96x	Cost of revenue / average inventory.
Days inventory	380 days	365 x average inventory / cost of revenue.
Receivables turnover	18.5x	Revenue / average receivables.
Days sales outstanding	20 days	365 x average receivables / revenue.
Days payables	75 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	325 days	Days inventory + days sales outstanding - days payables.
FCF conversion	-337.7%	Free cash flow / net income, when net income is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.22	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$21.65	Revenue / diluted weighted shares.
FCF per share	-$7.48	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$2.51	Cash from operations / diluted weighted shares.
Book value per share	$38.62	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$37.85	Tangible book value / shares outstanding.
Cash per share	$85.35	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$2.93B	Share price x shares outstanding.
Enterprise value	$2.24B	Market cap + total debt - cash - short-term investments.
P/E	60.5x	Market cap / net income. Only when net income is positive.
P/S	6.19x	Market cap / revenue.
P/B	3.47x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.54x	Market cap / tangible book value, when positive.
EV/Sales	4.73x	Enterprise value / revenue.
EV/EBIT	303x	Enterprise value / operating income, when both are positive.
EV/EBITDA	132x	Enterprise value / EBITDA, when both are positive.
FCF yield	-5.6%	Free cash flow / market cap.
Earnings yield	1.7%	Net income / market cap (the inverse of P/E).
PEG	12.4x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was CENTRUS ENERGY CORP's revenue in fiscal 2025?

CENTRUS ENERGY CORP reported revenue of $448.7M for fiscal 2025, 1.5% higher than the year before.

Was CENTRUS ENERGY CORP profitable in fiscal 2025?

Yes. Net income was $77.8M, a net margin of 17.3%.

How much free cash flow did CENTRUS ENERGY CORP generate in fiscal 2025?

Cash from operations of $51.0M minus capital expenditures of $19.7M left free cash flow of $31.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CENTRUS ENERGY CORP